14-day Premium Trial Subscription Try For FreeTry Free
$82.44
-1.36 (-1.62%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $80.50 $93.35 Friday, 3rd May 2024 BMRN stock ended at $82.44. This is 1.62% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 3.01% from a day low at $82.32 to a day high of $84.80.
90 days $80.50 $94.15
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
Jan 19, 2022 $86.83 $87.85 $85.72 $86.00 985 800
Jan 18, 2022 $90.17 $90.17 $86.54 $86.71 1 308 000
Jan 14, 2022 $87.61 $90.32 $86.40 $90.22 1 349 400
Jan 13, 2022 $87.86 $89.70 $87.63 $88.16 1 110 300
Jan 12, 2022 $89.15 $91.00 $87.60 $88.10 2 041 400
Jan 11, 2022 $84.37 $89.07 $84.30 $88.99 1 811 000
Jan 10, 2022 $87.10 $88.04 $82.00 $84.39 4 496 600
Jan 07, 2022 $86.40 $88.27 $84.17 $84.25 1 613 100
Jan 06, 2022 $84.33 $85.95 $83.23 $85.19 1 018 500
Jan 05, 2022 $87.22 $87.62 $83.99 $84.33 1 696 100
Jan 04, 2022 $88.98 $89.29 $85.53 $87.22 1 328 609
Jan 03, 2022 $88.10 $89.43 $87.10 $89.36 708 405
Dec 31, 2021 $88.96 $90.07 $88.22 $88.35 424 944
Dec 30, 2021 $89.81 $90.79 $88.98 $89.08 433 346
Dec 29, 2021 $89.55 $89.80 $88.41 $89.65 487 834
Dec 28, 2021 $90.50 $90.88 $89.22 $89.43 406 243
Dec 27, 2021 $90.74 $91.18 $90.12 $90.69 532 030
Dec 23, 2021 $90.02 $91.74 $89.51 $91.16 664 558
Dec 22, 2021 $89.79 $90.36 $88.55 $89.95 735 485
Dec 21, 2021 $87.11 $89.89 $87.00 $89.65 1 415 378
Dec 20, 2021 $85.55 $87.43 $85.05 $86.89 1 253 761
Dec 17, 2021 $83.33 $87.97 $82.65 $86.48 2 222 161
Dec 16, 2021 $85.00 $85.61 $82.67 $83.59 1 263 862
Dec 15, 2021 $82.71 $84.68 $81.94 $84.18 1 755 541
Dec 14, 2021 $83.06 $84.02 $82.08 $82.92 1 468 700
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT